Ultra-High Dose Rate Helium Ion Beams: Minimizing Brain Tissue Damage while Preserving Tumor Control
Ivana Đokić, Mahmoud Moustafa, Thomas Tessonnier, Sarah Meister, Federica Ciamarone, Mahdi Akbarpour, Damir Krunic, T. Haberer, Jürgen Debus, Andrea Mairani, Amir Abdollahi
This study compares ultra-high-dose rate helium ion radiotherapy (FLASH) with standard dose rate (SDR) in mice, showing FLASH reduces brain injury and neuroinflammation while maintaining tumor control.
Molecular Cancer Therapeutics · Dec 31, 2024Peer-reviewedCell Biology